Skip to main content
. 2022 Jul 1;12:896978. doi: 10.3389/fcimb.2022.896978

Figure 5.

Figure 5

Minimal biofilm eradication concentration against residual in vivo biofilm after vortex-sonication-vortex-method. (in vivo implant MBEC) of UAMS-1 (A, B) and USA300LAC (C, D). Bars in each graph indicate the median of five assays. **: p < 0.01 and *: p < 0.05 by Kruskal–Wallis test with Dunn’s multiple comparison. GM, gentamicin; VA, vancomycin; CZ, cefazolin.